ATE293107T1 - Luminacine analoge und deren verwendung - Google Patents

Luminacine analoge und deren verwendung

Info

Publication number
ATE293107T1
ATE293107T1 AT02794322T AT02794322T ATE293107T1 AT E293107 T1 ATE293107 T1 AT E293107T1 AT 02794322 T AT02794322 T AT 02794322T AT 02794322 T AT02794322 T AT 02794322T AT E293107 T1 ATE293107 T1 AT E293107T1
Authority
AT
Austria
Prior art keywords
luminacine
analogue
methods
cancer
synthesis
Prior art date
Application number
AT02794322T
Other languages
English (en)
Inventor
Frank Fang
Charles Johannes
Ye Yao
Xiaojie Jeff Zhu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE293107T1 publication Critical patent/ATE293107T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02794322T 2001-12-28 2002-12-18 Luminacine analoge und deren verwendung ATE293107T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34367801P 2001-12-28 2001-12-28
PCT/US2002/040744 WO2003057685A1 (en) 2001-12-28 2002-12-18 Luminacin analogs and uses thereof

Publications (1)

Publication Number Publication Date
ATE293107T1 true ATE293107T1 (de) 2005-04-15

Family

ID=23347131

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02794322T ATE293107T1 (de) 2001-12-28 2002-12-18 Luminacine analoge und deren verwendung

Country Status (7)

Country Link
US (2) US20050228039A1 (de)
EP (1) EP1458702B1 (de)
JP (1) JP4443228B2 (de)
AT (1) ATE293107T1 (de)
AU (1) AU2002359762A1 (de)
DE (1) DE60203740T2 (de)
WO (1) WO2003057685A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037299A1 (ja) * 2005-09-28 2007-04-05 Eisai R & D Management Co., Ltd. Ｈｂ２４の発現または転写調節活性を抑制する物質、その用途、およびその物質のスクリーニング法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116686A (ja) 1981-12-29 1983-07-11 Idemitsu Kosan Co Ltd オクタン誘導体、その製造法およびその用途
JPS61293920A (ja) 1985-06-24 1986-12-24 Idemitsu Kosan Co Ltd 免疫抑制剤
JPS62294619A (ja) 1986-06-16 1987-12-22 Idemitsu Kosan Co Ltd 抗白癬菌剤
JPS6322583A (ja) 1986-07-15 1988-01-30 Idemitsu Kosan Co Ltd Ｓｉ−４２２８系物質およびそれを有効成分とする殺菌剤
JPS6348213A (ja) 1986-08-15 1988-02-29 Idemitsu Kosan Co Ltd 抗腫瘍剤
JPH08268888A (ja) 1995-03-28 1996-10-15 Kyowa Hakko Kogyo Co Ltd 骨粗鬆症予防および治療剤
AU3538699A (en) 1998-05-18 1999-12-06 Eisai Co. Ltd. Novel physiologically active substances

Also Published As

Publication number Publication date
US20080249320A1 (en) 2008-10-09
US7642284B2 (en) 2010-01-05
JP2005519889A (ja) 2005-07-07
WO2003057685A1 (en) 2003-07-17
JP4443228B2 (ja) 2010-03-31
EP1458702A1 (de) 2004-09-22
DE60203740T2 (de) 2006-02-02
US20050228039A1 (en) 2005-10-13
EP1458702B1 (de) 2005-04-13
AU2002359762A1 (en) 2003-07-24
DE60203740D1 (de) 2005-05-19

Similar Documents

Publication Publication Date Title
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
PL367682A1 (en) Dolastatin 10 derivatives
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2003080582A3 (de) Fredericamycin-derivate
BR0215360A (pt) Derivados de indolina úteis como inibidores de proteìna quinase
ATE408601T1 (de) Fredericamycin-derivate
DK1200412T3 (da) Antiproliferative imidazolforbindelser
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
ATE369355T1 (de) Pyrimidinamid derivate und deren verwendung
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
WO2005030794A3 (en) Hemiasterlin derivatives and uses thereof
SE0003476D0 (sv) Compounds
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
BRPI0415355A (pt) triarilimidazóis
ATE293107T1 (de) Luminacine analoge und deren verwendung
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties